MD Anderson and TOPPAN Holdings announce strategic alliance to co-develop organoid technology for evaluating cancer treatments
Âé¶¹Ó³» MD Anderson Cancer Center and TOPPAN Holdings today announced a strategic alliance...

UT MD Anderson and Texas Children’s Hospital announce $150 million gift from Kinder Foundation to launch Kinder Children’s Cancer Center
Âé¶¹Ó³» MD Anderson Cancer Center and Texas Children’s Hospital today announced a $150 million gift from Kinder Foundation...
MD Anderson and UT Austin launch joint initiative to advance breakthroughs in cancer research
Âé¶¹Ó³» MD Anderson Cancer Center and Âé¶¹Ó³» at Austin have launched a joint initiative, the Collaborative...
UT MD Anderson and Texas Children’s Hospital Announce Joint Venture to End Childhood Cancer
Âé¶¹Ó³» MD Anderson Cancer Center and Texas Children’s Hospital have announced a transformational collaboration dedicated solely to pediatric cancer care. Approved by the UT System Board of Regents and the Texas Children’s Board of Trustees, this new, first-of-its-kind joint venture will unite the nation’s largest comprehensive pediatric system and a top pediatric cancer program with the nation’s leading comprehensive...

MD Anderson and Myriad Genetics form strategic alliance to evaluate clinical utility of Myriad’s molecular residual disease assay
Âé¶¹Ó³» MD Anderson Cancer Center and Myriad Genetics, Inc. today announced a five-year strategic alliance to accelerate the...
MD Anderson’s Lauren Averett Byers receives TAMEST O’Donnell Award for seminal contributions to lung cancer research
Lauren Averett Byers, M.D., professor of Thoracic/Head & Neck Medical Oncology at Âé¶¹Ó³» MD Anderson Cancer Center...
MD Anderson and AmMax Bio announce agreements to advance development of AMB-066 in colorectal cancer patients with minimal residual disease
Âé¶¹Ó³» MD Anderson Cancer Center and AmMax Bio, Inc. today announced a worldwide exclusive license agreement and clinical...
MD Anderson statement on BCBS TX ending Medicare Advantage and Medicaid plans
Blue Cross Blue Shield notified Âé¶¹Ó³» MD Anderson Cancer Center it will end its Letter of Agreement for Medicare Advantage...
Allison Institute scientific symposium features spatial biology breakthroughs, $5 million gift to support further efforts
The James P. Allison Institute™ at Âé¶¹Ó³»Â MD Anderson Cancer Center hosted its second annual scientific...
MD Anderson and Summit Therapeutics announce strategic collaboration to accelerate development of ivonescimab
Âé¶¹Ó³» MD Anderson Cancer Center and Summit Therapeutics, Inc. today announced a strategic five-year collaboration agreement...